Prakash Shahana, Vander Weg Mark, Tanaka Tomohiro
Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Department of Community and Behavioral Health, University of Iowa College of Public Health, Iowa City, Iowa, USA.
Liver Int. 2025 Jan;45(1):e16226. doi: 10.1111/liv.16226.
Racial/ethnic disparities have been previously reported in renal and hepatic disease care; however, acute kidney injury (AKI) in the setting of cirrhosis (hepatorenal syndrome [HRS]-AKI) despite its complexity requiring a multidisciplinary approach, remains understudied.
To identify unique associations of clinical and sociodemographic factors with mortality and length of stay (LOS) among patients hospitalised with HRS-AKI, hierarchical regression analysis was conducted, along with a mediation analysis to estimate how race-related differences in in-hospital mortality were influenced by payer type, area household income, and clinical severity.
Black patients demonstrated a significantly higher odds of in-hospital mortality, compared to their white counterparts, adjusting for (1) sex and age, (2) sex, age, payer type, and area household income and (3) sex, age, and clinical severity [OR 1.16-1.20, 95% confidence intervals (CI) > 1]. Higher mortality rates among Black patients were partially mediated by clinical severity and area household income [proportion mediated (PM): 0.19 and 0.17, respectively]. Black patients with HRS-AKI had longer LOS than White patients. Hispanic patients tended to have lower odds of in-hospital mortality [OR: 0.86] despite their lower income and more severe illness.
Our nationwide US study demonstrated that, partly due to higher clinical severity and lower household income, Black patients with HRS-AKI experience higher inpatient mortality, compared to White patients. On the other hand, Hispanics with HRS-AKI have a survival advantage. More awareness is warranted to address racial disparities in HRS-AKI outcomes.
先前已有关于肾脏和肝脏疾病护理中种族/民族差异的报道;然而,肝硬化背景下的急性肾损伤(肝肾综合征[HRS]-AKI)尽管其复杂性需要多学科方法,但仍研究不足。
为了确定临床和社会人口学因素与HRS-AKI住院患者死亡率和住院时间(LOS)之间的独特关联,进行了分层回归分析,并进行了中介分析,以估计支付方类型、地区家庭收入和临床严重程度如何影响住院死亡率的种族相关差异。
在调整了(1)性别和年龄、(2)性别、年龄、支付方类型和地区家庭收入以及(3)性别、年龄和临床严重程度后,黑人患者的住院死亡率明显高于白人患者[比值比(OR)为1.16 - 1.20,95%置信区间(CI)>1]。黑人患者较高的死亡率部分由临床严重程度和地区家庭收入介导[介导比例(PM)分别为0.19和0.17]。患有HRS-AKI的黑人患者的住院时间比白人患者长。西班牙裔患者的住院死亡率往往较低[OR:0.86],尽管他们收入较低且病情更严重。
我们在美国全国范围内的研究表明,部分由于更高的临床严重程度和更低的家庭收入,患有HRS-AKI的黑人患者与白人患者相比,住院死亡率更高。另一方面,患有HRS-AKI的西班牙裔患者具有生存优势。有必要提高对解决HRS-AKI结局中种族差异的认识。